Uncategorized
-
Vanderbilt researchers take leadership role in COVID-19 vaccine development
by Marissa Shapiro Dec. 18, 2020, 11:55 AM Work on COVID-19 theraputics at Vanderbilt University Medical Center (VUMC) As the United States and the rest of the world witness the rollout of new vaccines targeting COVID-19—as well as better treatment options to fight the… Read MoreDecember 18, 2020
-
ANCORA INNOVATIONS – Vanderbilt University | Deerfield
REQUEST FOR APPLICATIONS Rare Genetic Diseases Opening January 2021 Rolling Submission-Review Ancora Innovations is a collaboration between Vanderbilt University and Deerfield Management, focused on the union of Vanderbilt’s innovative life science discovery efforts and Deerfield’s commitment to accelerating state-of-the-art drug development. Deerfield will fund Ancora Innovation with up to $65… Read MoreDecember 17, 2020
-
Medium spiny neurons and “sticking” to bad habits
By Alexandra Fuller By the time March rolls around, New Year’s resolutions to ditch the expensive lattes and spend less time (and money) shopping online are often far behind us. Activity within the nucleus accumbens, a region of the brain implicated in motivation and addiction, may be at play. Read MoreDecember 15, 2020
-
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
by Marissa Shapiro Nov. 17, 2020, 12:00 PM Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University’s innovative life science research, will fund further research into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves. This is the third Vanderbilt project… Read MoreNovember 18, 2020
-
A visiting scholar’s experience with the lockdown in Nashville
By Naotoshi Nakamura Dr. Nakamura, a Specially Appointed Associate Professor at the Center for Mathematical Modeling and Data Science, Osaka University, was a visiting scholar in the Vito Quaranta lab and has since become a long-distance participant in discussions and lab meetings. Nakamura has also been appointed as… Read MoreOctober 7, 2020
-
Understanding sex-based behaviors may improve psychiatric treatments
By Sara Eaton There are biological differences in how male and female mice respond to different cues in their environment. Deciphering those differences can help researchers develop drugs that work equally well in both human sexes. New research from the labs of Erin Calipari and Cody Siciliano, both… Read MoreAugust 5, 2020
-
Cellular stress regulates β-cell dysfunction in type 2 diabetes
By Heather Caslin Approximately 30 million Americans have type 2 diabetes. The majority are over 45 years old. © Vitalii Vodolazskyi, stock.adobe.com Within the pancreas, β-cells produce insulin that delivers energy to tissues through glucose. People with type 2 diabetes have smaller, less functional β-cells; however, the mechanisms that drive… Read MoreJune 26, 2020
-
Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders
by Ryan Underwood Jun. 16, 2020, 4:23 PM Vanderbilt University’s Warren Center for Neuroscience Drug Discovery has entered into an exclusive worldwide licensing and collaboration agreement with San Diego-based ACADIA Pharmaceuticals Inc., which will seek to develop and commercialize treatments for central… Read MoreJune 18, 2020
-
Biomedical umbrella programs recruit the cream of the crop
By Beth Bowman and Lorena Infante Lara Recruiting for Fall 2020 admission in the Interdisciplinary Graduate Program in Biomedical Sciences and the Quantitative and Chemical Biology program wrapped up earlier this month with a banner year. Both umbrella programs saw an increase in the number and… Read MoreApril 29, 2020
-